SCL

$46.85

Post-MarketAs of Mar 17, 8:00 PM UTC

Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$46.85
Potential Downside
17.8%
Whystock Fair Value$38.49
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorBasic Materials
IndustrySpecialty Chemicals

Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and international...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.06B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
22.85
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.04
Div Yield
Strong income play. Yield provides a meaningful total return floor.
336.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
3.89%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.78

Recent News

Insider Monkey
Feb 28, 2026

Stepan Company (SCL): A Bull Case Theory

We came across a bullish thesis on Stepan Company on Danny’s Substack’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on SCL. Stepan Company’s share was trading at $66.46 as of February 17th. SCL’s trailing and forward P/E were 33.73 and 19.01 respectively according to Yahoo Finance. Stepan Company operates across diversified chemical […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Feb 25, 2026

Stepan (SCL) Launches Project Catalyst to Drive $100M in Cost Savings

Stepan Company (NYSE:SCL) is included among the 13 Most Promising Long-Term Stocks to Buy According to Hedge Funds. On February 23, Stepan Company (NYSE:SCL) announced Project Catalyst, which is a restructuring and efficiency initiative aimed at generating about $100 million in pre-tax savings over the next two years. The plan focuses on simplifying operations, reducing […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
24/7 Wall St.
Feb 24, 2026

3 Dividend Kings That Have Raised Payouts for 50+ Years and Still Look Cheap

Dividend King stocks are surprisingly cheap across the board because most investors are still heavily leaning on growth stocks. Stocks like Stepan Co (NYSE:SCL), Marzetti (NASDAQ:MZTI), and American States Water (NYSE:AWR) can get you both a handsome yield and healthy upside on top when the pendulum eventually swings the other way. If you expect the ... 3 Dividend Kings That Have Raised Payouts for 50+ Years and Still Look Cheap

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 24, 2026

Why Stepan (SCL) Is Down 19.8% After Q4 Earnings, Goodwill Impairment And Cost-Saving Push

Stepan Company recently reported past fourth-quarter 2025 results, with sales of US$553.89 million and net income of US$5.00 million, booked a US$6.25 million goodwill impairment, and declared a quarterly dividend of US$0.395 per share payable on March 13, 2026. Alongside steady dividend growth for the 58th consecutive year, Stepan launched Project Catalyst and continued ramping up its new Pasadena alkoxylation facility, aiming for significant cost efficiencies and a sharper manufacturing...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
GuruFocus.com
Feb 23, 2026

Stepan Co (SCL) Q4 2025 Earnings Call Highlights: Strong EBITDA Growth Amid Challenges

Stepan Co (SCL) reports a 6% increase in adjusted EBITDA and a positive free cash flow, while navigating raw material pressures and strategic facility closures.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.